Trial Eligibility, Treatment Patterns and Outcome for Venetoclax-Based Therapy in AML: a Prospective Cohort Study
Blood Advances(2024)
Key words
Acute Myeloid Leukemia (AML),Venetoclax,Hypomethylating agents,Hematopoietic Stem Cell Transplantation (HSCT)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined